BDHK-2009
/ Benethera Biotechnology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 09, 2026
A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
(clinicaltrials.gov)
- P1 | N=68 | Recruiting | Sponsor: Benethera (Shaoxing) Biotechnology Co., Ltd.
New P1 trial • Crohn's disease • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease • Ulcerative Colitis
1 to 1
Of
1
Go to page
1